| Lutheran Community At Telford | |
| 12 Lutheran Home Drive, Telford, Pennsylvania 18969 | |
| (215) 723-9819 | |
| Name | Lutheran Community At Telford |
|---|---|
| Location | 12 Lutheran Home Drive, Telford, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 75 |
| Occupancy Rate | 72.53% |
| Medicare ID (CCN) | 395804 |
| Legal Business Name | Lutheran Community At Telford |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
"The United Nations warned on Tuesday that a lack of aid money for Haiti was putting hundreds of thousands of displaced people at risk by forcing humanitarian agencies to cut services in one of the world's poorest countries," Reuters reports.
Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) researchers are recruiting women for a study to determine whether practicing yoga will help reduce symptoms of urinary incontinence.
It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma - the deadliest form of skin cancer - every hour.
Spreading of the epithelial cell layer is fundamental for epithelial closure and wound healing, as well as for embryonic development. The challenge presented here is that the cell layer needs to increase in surface area, but nevertheless maintain its integrity.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 7.94 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.4 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 83.67 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.16 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.08 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.92 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.59 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.78 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.31 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.66 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.98 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.66 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 89.58 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 81.73 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 64.55 | 82.93 |
News Archive
EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.
"The United Nations warned on Tuesday that a lack of aid money for Haiti was putting hundreds of thousands of displaced people at risk by forcing humanitarian agencies to cut services in one of the world's poorest countries," Reuters reports.
Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) researchers are recruiting women for a study to determine whether practicing yoga will help reduce symptoms of urinary incontinence.
It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma - the deadliest form of skin cancer - every hour.
Spreading of the epithelial cell layer is fundamental for epithelial closure and wound healing, as well as for embryonic development. The challenge presented here is that the cell layer needs to increase in surface area, but nevertheless maintain its integrity.
› Verified 8 days ago
Lutheran Community At Telford Location: 12 Lutheran Home Drive, Telford, Pennsylvania 18969 Phone: (215) 723-9819 |